52 Week Range
As of on the NASDAQ ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
GenMark Diagnostics Reports Fourth Quarter And Full Year 2020 Results
Genmark Diagnostics Sees FY 2020 Revenue About $171 Million
Genmark Diagnostics Reports Qtrly Net Loss Per Share, Basic And Diluted $0.05
GenMark Diagnostics, Inc. is a molecular diagnostics company. The Company is focused on developing and commercializing multiplex molecular tests that aid in the diagnosis of complex medical conditions. It develops and commercializes multiplex molecular tests based on its eSensor electrochemical detection technology. It offers four Food and Drug Administration (FDA)-cleared diagnostic tests which run on its XT-8 instrument; its Respiratory Viral Panel; its Cystic Fibrosis Genotyping Test; its Warfarin Sensitivity Test, and its Thrombophilia Risk Test. It also offers a Hepatitis C (HCV) genotyping test and associated custom manufactured reagents, as well as a 2C19 Genotyping Test, versions of which are available for use with its XT-8 instrument for research use only (RUO). Its XT-8 and ePlex test cartridges utilize the combination of distinct electrodes and multiple signal probes to detect dozens of target biomarkers from a single sample, thereby enabling highly multiplexed testing.
Medical Equipment & Supplies
5964 La Place Ct
Kevin C. O'Boyle
Independent Chairman of the Board
President, Chief Executive Officer, Director
Chief Financial Officer
Senior Vice President, General Counsel, Secretary
Senior Vice President - Sales
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
U.S. laboratory products supplier Avantor has agreed to buy German peer Ritter for 890 million euros ($1.1 billion) in cash, adding to a wave of dealmaking in the sector.
Italian diagnostics firm DiaSorin has agreed to buy U.S. rival Luminex Corp for $1.8 billion in a move that could boost its molecular business and offset a potential drop in demand for COVID-19 tests as the pandemic is brought under control.
* Flutter lifts travel and leisure stocks (Adds comments, updates prices throughout)
European stocks rose on Monday on gains in French food company Danone and Swiss drugmaker Roche Holding, with optimism about a strong economic rebound calming concerns about quickening inflation.
As drugmakers race to develop vaccines and therapies for the novel coronavirus, the United States is rushing to secure access to them. The U.S. government has agreed to invest more than $7 billion in vaccines and has funded more than 30 projects, including for diagnostics...
* Q1 EARNINGS PER SHARE VIEW $-0.22 -- THOMSON REUTERS I/B/E/S
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.